top of page

William Blair's Andy Hsieh returns to Analyst Thursdays to talk radiopharma buyouts, obesity and more

Andy Hsieh gives his take on the radiopharmaceutical space, Viking’s obesity data, Pyxis Oncology, Cardiff Oncology, and Fibrogen.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page